Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)
China · Delayed Price · Currency is CNY 12.82
+0.46 (3.72%)
Aug 20, 2026, 3:00 PM CST
SHA:600557 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 7,258 | 7,989 | 7,756 | 11,999 | 10,961 | 7,055 | |
Market Cap Growth | -35.35% | 3.00% | -35.36% | 9.47% | 55.36% | 17.01% |
Enterprise Value | 5,418 | 6,033 | 5,802 | 9,984 | 9,682 | 6,533 |
Last Close Price | 12.82 | 14.11 | 13.62 | 20.09 | 18.13 | 11.84 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 24.18 | 26.28 | 19.79 | 25.85 | 25.23 | 22.01 |
Forward PE | 21.19 | 14.69 | 12.25 | 19.80 | 22.32 | 16.11 |
PS Ratio | 2.24 | 2.43 | 1.99 | 2.47 | 2.52 | 1.93 |
PB Ratio | 1.43 | 1.59 | 1.65 | 2.39 | 2.22 | 1.58 |
P/TBV Ratio | 1.58 | 1.77 | 1.81 | 2.56 | 2.46 | 1.78 |
P/FCF Ratio | - | 89.95 | 34.35 | 18.15 | 13.97 | 9.58 |
P/OCF Ratio | 12.11 | 13.08 | 11.04 | 12.34 | 11.01 | 7.77 |
PEG Ratio | - | 1.22 | 1.11 | 0.66 | 1.80 | 1.80 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.67 | 1.83 | 1.49 | 2.05 | 2.23 | 1.79 |
EV/EBITDA Ratio | 12.76 | 13.89 | 11.77 | 16.52 | 16.44 | 12.88 |
EV/EBIT Ratio | 22.33 | 24.22 | 19.79 | 24.38 | 24.27 | 20.41 |
EV/FCF Ratio | - | 67.92 | 25.69 | 15.10 | 12.34 | 8.87 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0 | 0.08 | 0.10 | 0.09 | 0 | 0.05 |
Debt / EBITDA Ratio | 0.00 | 0.94 | 0.99 | 0.70 | 0.00 | 0.47 |
Debt / FCF Ratio | - | 4.59 | 2.16 | 0.64 | 0.00 | 0.32 |
Net Debt / Equity Ratio | -0.40 | -0.35 | -0.37 | -0.40 | -0.36 | -0.20 |
Net Debt / EBITDA Ratio | -4.80 | -4.01 | -3.54 | -3.33 | -3.00 | -1.73 |
Net Debt / FCF Ratio | 152.76 | -19.60 | -7.74 | -3.05 | -2.25 | -1.19 |
Asset Turnover | 0.47 | 0.48 | 0.55 | 0.70 | 0.68 | 0.60 |
Inventory Turnover | 1.94 | 1.94 | 2.39 | 3.62 | 3.57 | 2.87 |
Quick Ratio | 1.61 | 1.60 | 1.44 | 1.73 | 1.83 | 1.70 |
Current Ratio | 1.94 | 1.93 | 1.76 | 2.00 | 2.09 | 1.98 |
Return on Equity (ROE) | 6.11% | 6.33% | 7.83% | 8.92% | 9.40% | 7.37% |
Return on Assets (ROA) | 2.20% | 2.26% | 2.60% | 3.66% | 3.89% | 3.30% |
Return on Invested Capital (ROIC) | 6.61% | 6.89% | 9.74% | 13.16% | 11.70% | 8.28% |
Return on Capital Employed (ROCE) | 4.60% | 4.80% | 6.00% | 8.00% | 8.00% | 7.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.13% | 3.81% | 5.05% | 3.87% | 3.96% | 4.54% |
FCF Yield | -0.18% | 1.11% | 2.91% | 5.51% | 7.16% | 10.44% |
Dividend Yield | - | - | - | 1.85% | 1.21% | - |
Payout Ratio | 30.65% | 30.24% | 54.50% | 27.69% | 0.57% | 3.45% |
Buyback Yield / Dilution | 3.38% | 2.33% | 0.68% | -0.16% | -1.20% | 4.21% |
Total Shareholder Return | 3.38% | 2.33% | 0.68% | 1.70% | 0.01% | 4.21% |